Abpro Holdings, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY, 10013
Mailing Address 6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY, 10013
Phone 248-890-7200
Fiscal Year End 1231
EIN 871013956
Financial Overview
FY2024 FY
$183K
Revenue
$4.66M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 11, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 9, 2026 | View on SEC |
| 8-K Current report of material events | February 3, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| 8-K Current report of material events | December 15, 2025 | View on SEC |
| 8-K Current report of material events | December 9, 2025 | View on SEC |
| S-1/A IPO registration amendment | November 28, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| S-1 IPO registration statement | November 7, 2025 | View on SEC |
Material Events
8-K Financial Distress December 9, 2025
High Impact
- Abpro Holdings, Inc. received an extension from Nasdaq to regain compliance with listing requirements.
- This extension prevents the company's immediate delisting from the Nasdaq exchange.
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.